D-0631-2021 Class III Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0631-2021 was initiated by AVKARE Inc. on Jun 9, 2021 and is designated Class III. Reason for recall: Failed Impurities Specification: Out of specification when measuring the impurity degradant D level. The recall status is terminated (terminated Jun 2, 2023). Affected quantity: 10 cartons.

Recall details

Product Type
Drugs
Report Date
Jun 23, 2021
Initiation Date
Jun 9, 2021
Termination Date
Jun 2, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10 cartons

Product description

Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13

Reason for recall

Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

Distribution pattern

Distributed in Los Angeles California

Code information

Lot: 38617 Exp. 10/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0631-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0631-2021. Report a data issue: hello@regdatalab.com.